Tags:BrandDeliveryDrugPublicTechnology
Insulet is a publicly traded drug delivery company with a novel insulin pump technology marketed under the OmniPod brand. Insulet is a publicly traded drug delivery company with a novel insulin pump technology marketed under the OmniPod brand. Insulet went public in 2007. Insulet went public in 2007.
Location: United States, Massachusetts, Bedford
Member count: 1001-5000
Founded date: 2000

Investors 2

Mentions in press and media 6

DateTitleDescriptionCategoryAuthorSource
02.02.2016Insulet to...BILLERICA, Mass. – February 2,...--pbcap.com/...
13.06.2014Joslin exe...“We see that the future is wit...--medcitynew...
05.03.2013Diabetes: ...Medical device maker Insulet (...-Arezu Sarv...massdevice...
22.01.2010Breath-bas...I guess since I’m the resident...conspiraci...-techcrunch...
16.05.2007Insulet, i...Insulet, a Bedford, Mass, deve...--venturebea...
-Joslin exe...This week Joslin Center for Di...--medcitynew...